Independent Financial Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
13,536
+4,650
+52% +$390K 0.02% 611
2026
Q1
$712K Sell
8,886
-1,748
-16% -$144K 0.02% 760
2025
Q4
$907K Sell
10,634
-2
-0% -$164 0.02% 655
2025
Q3
$827K Sell
10,636
-2,376
-18% -$186K 0.02% 665
2025
Q2
$1.02M Buy
13,012
+2,020
+18% +$151K 0.03% 539
2025
Q1
$797K Buy
10,992
+1,957
+22% +$140K 0.03% 548
2024
Q4
$669K Sell
9,035
-2,051
-19% -$144K 0.02% 603
2024
Q3
$732K Sell
11,086
-1,364
-11% -$99.1K 0.03% 531
2024
Q2
$1.15M Buy
12,450
+1,135
+10% +$101K 0.05% 369
2024
Q1
$1.08M Sell
11,315
-916
-7% -$76.9K 0.05% 356
2023
Q4
$933K Buy
12,231
+2,706
+28% +$188K 0.05% 377
2023
Q3
$660K Buy
9,525
+167
+2% +$13.4K 0.04% 425
2023
Q2
$883K Sell
9,358
-30
-0.3% -$2.61K 0.06% 340
2023
Q1
$777K Sell
9,388
-1,460
-13% -$115K 0.06% 345
2022
Q4
$809K Sell
10,848
-408
-4% -$31.4K 0.07% 295
2022
Q3
$930K Sell
11,256
-757
-6% -$72.8K 0.08% 236
2022
Q2
$1.14M Sell
12,013
-282
-2% -$29.2K 0.12% 199
2022
Q1
$1.45M Sell
12,295
-1,600
-12% -$179K 0.12% 175
2021
Q4
$1.8M Buy
13,895
+845
+6% +$98.6K 0.15% 142
2021
Q3
$1.48M Buy
13,050
+843
+7% +$96.2K 0.15% 137
2021
Q2
$1.26M Buy
+12,207
New +$1.15M 0.13% 174

Other funds holding EW

Independent Financial Group's EW Position: Q2 2026 in Review

Independent Financial Group increased its Edwards Lifesciences (EW) stake by 52% in Q2 2026, buying an estimated $390K and bringing the position to 13,536 shares worth $1.22M. The position accounts for 0.02% of the portfolio, ranked #611.

Independent Financial Group first reported a position in EW in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.8M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Independent Financial Group held 13,536 shares of Edwards Lifesciences worth $1.22M as of Q2 2026.
  • Independent Financial Group bought 4,650 Edwards Lifesciences shares in Q2 2026, an estimated $390K.
  • Edwards Lifesciences made up 0.02% of Independent Financial Group's portfolio in Q2 2026, its #611 holding.
  • Independent Financial Group first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 21 quarters since.
  • Independent Financial Group's Edwards Lifesciences position peaked at $1.8M in Q4 2021.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.